Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose varenicline pharmacokinetics in healthy adolescent smokers
NL-OMON31381Phase 1Withdrawn
- Sponsor
- Pfizer
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of varenicline in nicotine dependence (3 arms), sponsored by Pfizer. Primary endpoint: Population mean estimate for apparent plasma clearance, central volume of distribution, and steady-state volume of distribution. Planned start Jun 2007; status: withdrawn.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NL-OMON31381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31381.